Botanical and Plant Derived Drugs Market, By Source, By Dosage Form, By Therapeutic Application, By Geography

Description

Botanical And Plant Derived Drugs Market is estimated to be valued at USD 52.6 Bn in 2026 and is expected to reach USD 80.7 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 52.6 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 80.7 Bn

Botanical and plant derived drugs contain active ingredients derived from plants. The botanical drug is a mixture of plant materials that include whole plant, part of plants, fungi or algae. Plants have been used as a source of medicine since past, owing to side effects caused due to consumption of synthetic drugs the botanical and plant derived drugs are preferred over the synthetic drugs.

Furthermore, the botanical drugs are clinically evaluated for safety and efficacy just as conventional drugs. Besides, this legalization of medical cannabis is also expected to foster growth of the botanical and plant derived drugs market.

Market Dynamics

The global botanical and plant derived drugs market is projected to witness significant growth over the forecast period, owing to legalization of medical cannabis. Medical cannabis was legalized in the Czech Republic, in 2013, Argentina and Chile in 2015, and in 2016, marijuana legalization in America reached a tipping point, as the medical marijuana became legal in some of the states.

Hence, many manufacturers are focused on research and development on medical cannabis to launch new drugs. For instance, one of the drug by GW Pharmaceuticals, Epidiolex consists of cannabidivarin (CBDV) is in developmental process, which will be used in clinical trials for treatment resistant epilepsy, supported by NSW and Queensland government in 2016.

Furthermore, increasing number of chronic disease supports the growth of botanical and plant derived drugs, as lung cancer accounts for the leading cause of death in the Eastern, Southern and Southeastern Asia. The region holds for 56% of the world's population and contributes to 44% of the total cancer cases worldwide according to the statistics mentioned in the Cancer Atlas.

Key features of the study

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by the leading players
It profiles leading players in the global botanical and plant derived drugs market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
Key companies covered as a part of this study include Bayer Healthcare, GlaxoSmithKline, Pfizer, Inc. Sanofi, Actelion Pharmaceuticals, Aimil Pharmaceuticals, Allergan, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Concordia Pharmaceuticals, GW Pharmaceuticals, LEO Pharma, MEDICAGO, and Merck.
Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, market expansion, and marketing tactics.
The global botanical and plant derived drugs market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for botanical and plant derived drugs market, research and consulting firms, new entrants, and financial analysts.

Market Segmentation

By Source (Revenue, USD Bn, 2021-2033)
- Plant
- Algae
- Macroscopic fungi
- Others
By Dosage Form (Revenue, USD Bn, 2021-2033)
- Pills
- Tablets
- Capsules
- Injection
By Therapeutic Application (Revenue, USD Bn, 2021-2033)
- Central Nervous System
- Cardiovascular Diseases
- Infectious Diseases
- Respiratory Diseases
By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- North Africa
- South Africa
- Central Africa
Key Players
- Bayer Healthcare
- GlaxoSmithKline
- Pfizer, Inc.
- Sanofi
- Actelion Pharmaceuticals
- Aimil Pharmaceuticals
- Allergan
- AstraZeneca
- Boehringer Ingelheim
- GW Pharmaceuticals

Product Code: CMI1737

1. Research Objective and Assumption

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Global Botanical and Plant Derived Drugs Market, By Source
- Global Botanical and Plant Derived Drugs Market, By Dosage Form
- Global Botanical and Plant Derived Drugs Market, By Therapeutic Application
- Global Botanical and Plant Derived Drugs Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Recent product launches
Regulatory Scenario
Awareness initiatives
PEST Analysis
PORTER's Analysis
Epidemiology

4. Global Botanical and Plant Derived Drugs Market, By Source, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Plant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Algae
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Macroscopic fungi
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

5. Global Botanical and Plant Derived Drugs Market, By Dosage Form, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Pills
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Injection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

6. Global Botanical and Plant Derived Drugs Market, By Therapeutic Application, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022-2033
- Segment Trends
Central Nervous System
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Cardiovascular Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)
Respiratory Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Billion)

7. Global Botanical and Plant Derived Drugs Market, By Regions, 2021 - 2033, (US$ Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, By Region, 2022 - 2033
- Regional Trends
North America
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - U.S.
  - Canada
Europe
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Latin America
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Asia Pacific
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - China
  - India
  - Japan
  - Australia
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Market Size and Forecast, By Source, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Dosage Form, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Therapeutic Application, 2021 - 2033, (US$ Billion)
- Market Size and Forecast, By Countries, 2021 - 2033, (US$ Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Bayer Healthcare
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- GlaxoSmithKline
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Pfizer, Inc.
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Sanofi
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Actelion Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Aimil Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Allergan
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- AstraZeneca
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- Boehringer Ingelheim
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
- GW Pharmaceuticals
  - Company Overview
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Strategies
  - Analyst Views

9. Section

References
Research Methodology
About Us and Sales Contact